COVID-19疫情期间纽约市医院抗菌药物管理视角:挑战与机遇
本文基于纽约市一家医院在COVID-19疫情早期数周的经验,分享抗菌药物管理项目面临的挑战与机遇。疫情期间诊断和治疗不确定性、医疗资源紧张,抗菌药物管理原则至关重要。通过加强沟通、教育和库存控制,并利用电子病历能力优化现有资源。
要点
- 疫情早期缺乏有效抗病毒药物,重症患者难以避免使用抗菌药物。
- 诊断与治疗不确定性驱动抗菌药物使用,抗菌药物管理原则至关重要。
- 加强沟通、教育、库存控制及利用电子病历可优化资源。
核心结论
- 纽约市在COVID-19疫情初期峰值期间环境独特且充满挑战。
- 抗菌药物管理项目可通过分享经验教训和实践机会相互学习,更好地为其他面对COVID-19病例激增的项目做准备。
研究设计与样本
- 基于一家中心在COVID-19疫情早期数周的经验分享。
主要发现
- 2020年春季纽约市迅速成为美国COVID-19疫情热点,给当地医疗系统带来压力。
- 抗菌药物管理项目面临诊断和治疗不确定性以及医疗资源挑战。
- 缺乏有效抗病毒药物时,重症患者难以避免使用抗菌药物。
- 不确定性驱动抗菌药物使用,抗菌药物管理原则至关重要。
- 患者大量涌入、药品和设备短缺以及处方者需承担替代角色使情况更加复杂。
临床怎么用
- 建立加强的沟通、教育和库存控制。
- 利用电子病历的能力优化现有资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To share challenges and opportunities for antimicrobial stewardship programs based on one center's experience during the early weeks of the coronavirus disease 2019 (COVID-19) pandemic. SUMMARY: In the spring of 2020, New York City quickly became a hotspot for the COVID-19 pandemic in the United States, putting a strain on local healthcare systems. Antimicrobial stewardship programs faced diagnostic and therapeutic uncertainties as well as healthcare resource challenges. With the lack of effective antivirals, antibiotic use in critically ill patients was difficult to avoid. Uncertainty drove antimicrobial use and thus antimicrobial stewardship principles were paramount. The dramatic influx of patients, drug and equipment shortages, and the need for prescribers to practice in alternative roles only compounded the situation. Establishing enhanced communication, education, and inventory control while leveraging the capabilities of the electronic medical record were some of the tools used to optimize existing resources. CONCLUSION: New York City was a unique and challenging environment during the initial peak of the COVID-19 pandemic. Antimicrobial stewardship programs can learn from each other by sharing lessons learned and practice opportunities to better prepare other programs facing COVID-19 case surges.
引用
- Kubin CJ, Loo AS, Cheng J, et al. Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities. Am J Health Syst Pharm. 2021. PMID: 33543233. doi:10.1093/ajhp/zxaa419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。